Renshen (Panax ginseng) and Huanglian (Rhizoma Coptidis) For T2DM: A protocol of systematic review and meta-analysis of randomized clinical trials
- PMID: 33466125
- PMCID: PMC7808494
- DOI: 10.1097/MD.0000000000023743
Renshen (Panax ginseng) and Huanglian (Rhizoma Coptidis) For T2DM: A protocol of systematic review and meta-analysis of randomized clinical trials
Abstract
Introduction: Type 2 diabetes mellitus (T2DM) is a metabolic disease characterized by high blood sugar caused by impaired insulin action. With an increasing incidence year by year, it has become a worldwide epidemic. Because of its serious, long-term condition, T2DM has a bad impact on the life and well-being of individuals, families and society. Renshen and Huanglian or compound prescription contain Renshen and Huanglian for treatment of T2DM has already been confirmed. However, due to the lack of evidence, there is no specific method or suggestion, so it is necessary to carry out systematic evaluation on Renshen and Huanglian and provide effective evidence for further research.
Methods and analysis: We will search English databases (PubMed, Embase, Web of Science, Nature, Science on line, the Cochrane Library) and Chinese databases (CNKI, Wan Fang, VIP, Chinese biomedical database), from the establishment of database to October 2020, for randomized controlled trials (RCTs) of ginseng and coptis and the compound containing ginseng and coptis in the treatment of T2DM. Primary outcomes: fasting blood-glucose (FBG), 2 Hours Postprandial Blood Glucose (2hPBG), Glycosylated hemoglobin A1c (HbA1c). Additional outcomes: Low Density Lipoprotein (LDL), High Density Lipoprotein (HDL), triglycerides (TG), total serum cholesterol (TC). Two researchers independently extracted the data and evaluated the quality of the included research, and meta-analysis was conducted on the included data using the software of RevMan5.3 and Stata V.12.0.
Results: The results of this study will systematically evaluate the effectiveness and safety of Renshen and Huanglian intervention for people with T2DM.
Conclusion: The systematic review of this study will summarize the current published evidence of Renshen and Huanglian or compound prescription contain Renshen and Huanglian for the treatment of T2DM, which can further guide the promotion and application of it.
Ethics and dissemination: This study is a systematic review; the outcomes are based on the published evidence, so examination and agreement by the ethics committee are not required in this study. We intend to publish the study results in a journal or conference presentations.
Open science framework osf registration number: October 18, 2020. osf.io/8gz7c (https://osf.io/8gz7c).
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
All authors involved in this work have no conflicts of interest.
Similar articles
-
Large dosage Huangqin (Scutellaria) and Huanglian (Rhizoma Coptidis) for T2DM: A protocol of systematic review and meta-analysis of randomized clinical trials.Medicine (Baltimore). 2020 Sep 18;99(38):e22032. doi: 10.1097/MD.0000000000022032. Medicine (Baltimore). 2020. PMID: 32957320 Free PMC article.
-
Large dosage Huanglian (Rhizoma Coptidis) for T2DM: A protocol of systematic review and meta-analysis of randomized clinical trials.Medicine (Baltimore). 2020 Sep 18;99(38):e22066. doi: 10.1097/MD.0000000000022066. Medicine (Baltimore). 2020. PMID: 32957328 Free PMC article.
-
Baihu Jia Renshen Decoction for type 2 diabetic mellitus: A protocol for systematic review and meta-analysis.Medicine (Baltimore). 2020 May;99(19):e20210. doi: 10.1097/MD.0000000000020210. Medicine (Baltimore). 2020. PMID: 32384518 Free PMC article.
-
Efficacy of Huanglian Jiedu Decoction for Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.Complement Med Res. 2024;31(2):187-200. doi: 10.1159/000536453. Epub 2024 Jan 29. Complement Med Res. 2024. PMID: 38286111 English.
-
Systematic review and meta-analysis of Coptis chinensis Franch.-containing traditional Chinese medicine as an adjunct therapy to metformin in the treatment of type 2 diabetes mellitus.Front Pharmacol. 2022 Sep 8;13:956313. doi: 10.3389/fphar.2022.956313. eCollection 2022. Front Pharmacol. 2022. PMID: 36160405 Free PMC article.
Cited by
-
Correlation Analysis of Huayu Tongmai Decoction Intervention and Prognosis Indexes of Patients with Carotid Atherosclerosis.Evid Based Complement Alternat Med. 2021 Oct 31;2021:2739092. doi: 10.1155/2021/2739092. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 35256887 Free PMC article.
-
Several major herb pairs containing Coptidis rhizoma: a review of key traditional uses, constituents and compatibility effects.Front Pharmacol. 2024 Jun 25;15:1399460. doi: 10.3389/fphar.2024.1399460. eCollection 2024. Front Pharmacol. 2024. PMID: 38983920 Free PMC article. Review.
-
The role of Chinese herbal medicine in the regulation of oxidative stress in treating hypertension: from therapeutics to mechanisms.Chin Med. 2024 Oct 29;19(1):150. doi: 10.1186/s13020-024-01022-9. Chin Med. 2024. PMID: 39468572 Free PMC article. Review.
References
-
- Ge Junbo, Xu Yongjian. Internal medicine. 8th EditionBeijing: People's Medical Publishing House; 2014.
-
- Saeedi P, Petersohn I, Salpea P, et al. IDF Diabetes Atlas Committee. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract 2019;157:107843. - PubMed
-
- Boule NG, Haddad E, Kenny GP, et al. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA 2001;286:1218–27. - PubMed
-
- Li hui, Yang yu-feng, Shi Yan. Therapeutic mechanism of supplementing qi and nourishing yin and promoting blood circulation Chinese materia medica on diabetes. Chin Arch Tradit Chin Med 1–8. 2020-11-09.
-
- Magkos F, Hjorth MF, Astrup A. Diet and exercise in the prevention and treatment of type 2 diabetes mellitus. Nat Rev Endocrinol 2020;16:545–55. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous